The traumatic brain injuries assessment market size is expected to see strong growth in the next few years. It will grow to $14.6 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated growth can be credited to an aging population, increasing incidence of accidents, enhanced diagnostics, expansion of healthcare infrastructure, and rising demand for personalized rehabilitation. Key trends expected include the adoption of telemedicine, integration of wearable technology, utilization of virtual reality therapy, implementation of personalized treatment approaches, and the use of AI-driven diagnostics.
The uptick in both sports injuries and road accidents is anticipated to drive the growth of the market for assessing traumatic brain injuries in the future. Sports injuries refer to physical harm sustained during sports or athletic activities, while road accidents involve incidents on roads resulting in injuries or damage, often due to factors such as increased participation in sports, traffic congestion, distracted driving, and insufficient safety measures. The assessment of traumatic brain injuries is crucial in these scenarios to evaluate the severity of head trauma, guide treatment decisions, and monitor recovery progress for optimal outcomes. For instance, in June 2023, the National Highway Transportation Safety Administration (NHTSA) reported approximately 966 pedal cyclists killed in 2021, marking a 1.9% increase from 2020. Additionally, in September 2022, a report from the Government Digital Service highlighted around 1,558 deaths in documented road traffic crashes in 2021, reflecting a 7% rise from 2020. Hence, the mounting instances of sports injuries and road accidents are propelling the demand for traumatic brain injury assessment.
Key players in the traumatic brain injuries assessment market are directing their efforts towards developing products featuring advanced technology, such as an AI-derived concussion index, aimed at enhancing diagnostic accuracy and treatment outcomes. This index utilizes AI capabilities to gauge the severity of a concussion based on various clinical indicators such as symptoms, cognitive function, and balance. For example, in March 2021, Brainscope Company Inc., a US-based medical technology firm, obtained FDA clearance for its next-generation AI-derived concussion index algorithm integrated into the BrainScope One device. This index facilitates rapid and objective assessment of patients for concussion both at the time of injury and during recovery. It offers improved insights into patients' initial brain function, injury severity, and recovery trajectory, potentially reducing the need for unnecessary CT scans in emergency departments by over 30% and minimizing radiation exposure for patients.
In April 2022, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, forged a partnership with Prisma Health to enhance patient care through data integration and maximizing the value of patient data. This collaboration aims to support Prisma Health's goal of enterprise interoperability and foster innovation in corporate imaging solutions, particularly in their outpatient brain injury program offering comprehensive rehabilitation services. Prisma Health is a US-based nonprofit healthcare organization.
Major companies operating in the traumatic brain injuries assessment market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Inc., Koninklijke Philips NV, Stryker Corporation, GE Healthcare Inc, Baxter International Inc., Agilent Technologies Inc, Bio-Rad Laboratories Inc., Canon Medical Systems Corporation, Bruker Corporation, Carestream Health Inc., Nihon Kohden Corp, Integra Lifesciences Corporation, Natus Medical Inc, Raumedic AG, Compumedics Limited, HALO Precision Diagnostics, NanoDx Inc., BrainScope Company Inc., Advanced Brain Monitoring Inc, Neuexcell Therapeutics, InfraScan Inc.
North America was the largest region in the traumatic brain injuries assessment market in 2023. The regions covered in the traumatic brain injuries assessment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the traumatic brain injuries assessment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Traumatic brain injury (TBI) assessment is a process that involves evaluating a person's cognitive, physical, and emotional functioning following an injury to the brain caused by an external force. This comprehensive process is typically conducted by medical professionals such as neurologists, neurosurgeons, or emergency room physicians to determine injury severity, pinpoint areas of impairment, and guide treatment and rehabilitation strategies. The aim is to comprehend the injury's impact on cognitive abilities, physical function, and emotional well-being to devise an appropriate management plan.
The primary products for TBI assessment include screening and monitoring devices. Screening tools swiftly identify potential issues or abnormalities in individuals, often before symptoms manifest or worsen. Monitoring devices, such as intracranial pressure (ICP) monitors and partial pressure of oxygen in brain tissue (pbro2) monitors, are utilized in hospital settings, diagnostics centers, and elsewhere.
The traumatic brain injuries assessment market research report is one of a series of new reports that provides traumatic brain injuries assessment market statistics, including traumatic brain injuries assessment industry global market size, regional shares, competitors with a traumatic brain injuries assessment market share, detailed traumatic brain injuries assessment market segments, market trends and opportunities, and any further data you may need to thrive in the traumatic brain injuries assessment industry. This traumatic brain injuries assessment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The traumatic brain injuries assessment market includes revenues earned by entities by providing diagnostic assessments, rehabilitation programs, care management, and counseling and psychosocial support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Traumatic Brain Injuries Assessment Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on traumatic brain injuries assessment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for traumatic brain injuries assessment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The traumatic brain injuries assessment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Screening Devices; Monitoring Devices2) By Technique: Intracranial Pressure (ICP) Monitoring; Partial Pressure Of Oxygen In Brain Tissue (pBrO2)
3) By End-User: Hospital; Diagnostics Center; Other End Users
Key Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic Inc.; Koninklijke Philips NV
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Roche Holding AG
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Medtronic Inc.
- Koninklijke Philips NV
- Stryker Corporation
- GE Healthcare Inc
- Baxter International Inc.
- Agilent Technologies Inc
- Bio-Rad Laboratories Inc.
- Canon Medical Systems Corporation
- Bruker Corporation
- Carestream Health Inc.
- Nihon Kohden Corp
- Integra Lifesciences Corporation
- Natus Medical Inc
- Raumedic AG
- Compumedics Limited
- HALO Precision Diagnostics
- NanoDx Inc.
- BrainScope Company Inc.
- Advanced Brain Monitoring Inc
- Neuexcell Therapeutics
- InfraScan Inc
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | July 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 10.8 Billion |
Forecasted Market Value ( USD | $ 14.6 Billion |
Compound Annual Growth Rate | 7.8% |
Regions Covered | Global |
No. of Companies Mentioned | 24 |